Phase I Study of Iadademstat with Hypomethylating Agent in Patients with Myelodysplastic Syndrome

Protocol No
IIT-GURU-IADADEMSTAT-MDS
Staff Member
Guru Subramanian Guru Murthy
Phase
I
Summary

This project is being done to look at the safety and tolerability of an investigational anticancer drug iadademstat, when given in combination with azacitidine.
Objective
Phase I Study of Iadademstat with Azacitidine in Patients with Myelodysplastic Syndrome
Status
OPEN TO ACCRUAL
Categories
Cancer, Hematologic/Blood Related Cancers
ClinicalTrials.gov
https://www.clinicaltrials.gov/study/NCT06502145